Skip to main content
OpenTrials
Completed

NCT Number: NCT06637384

Effect of Hyaluronic Acid and Single Dose Corticosteroid Injection to Improve Wound Healing in Controlled Diabetic Patients Post Tooth Extraction.

The goal of this clinical trial is to learn if hyaluronic acid and corticosteroid improves wound healing in diabetic patients after oral extraction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Department of Oral and Maxillofacial Surgery, Madinah Teaching Hospital, Faisalabad

Faisalabad, Punjab Province, 38000, Pakistan

About this study

After sample size estimation via Open Epi of 128, randomized clinical trial was performed on the patients from Oral and Maxillofacial Surgery Department in Madinah Teaching Hospital, Faisalabad. Patients were divided into three groups. Group 1 was subjected as control group, Group 2 was treated post extraction with 0.2 % Hyaluronic acid (Gengigel Gingival Gel 20ml, Ricerfarma, Milan, Italy) and Group 3 was treated with single dose Hy-Cortisone Injection 250 mg (Generic name: Hydrocortisone Sodium Succinate, Cirin Pharmaceuticals Pakistan) intramuscularly after extraction. Wound healing was assessed through Landry Healing Index. One-way ANOVA test was applied for comparative analysis and Post Hoc Tuckey's test was applied for pairwise comparisons between the groups

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Controlled diabetic patients who had random blood glucose levels of 80 to 130 mg/dl, according to World Health Organization.
  • Age was defined from 25-55, irrespective of the gender.
  • Tooth extractions in maxilla or mandible without the presence of an acute infection or compromised periodontal state.

Exclusion criteria

  • • Patients who declined to participate.
  • Patients below the age of 25 and above the age of 55.
  • Patients with uncontrolled diabetes mellitus (blood sugar levels high than the defined range)
  • Patients with history of adverse effects to local anesthetics or who are currently taking corticosteroids.
  • Patients with unmaintained oral hygiene and smoking habits.
  • Confirmation of any chronic illness, including those with hypertension or cardiac disorders.
  • Patients who have undergone any recent major surgical procedure.

Treatment and study plan

Hyaluronic Acid (HA)

Drug

Gengigel Gingival Gel 20ml, Ricerfarma, Milan, Italy

Other names: 0.2% Hyaluronic acid

Corticosteroid injection

Drug

Hydrocortisone Sodium Succinate, Cirin Pharmaceuticals, Pakistan

Primary outcomes

  1. Wound healing

    Time frame: 6 days

    The wound healing after follow was assessed via Landry Healing Index. This index had five grades very poor (1), poor (2), good (3), very good (4) and excellent (5). Each grade further had five parameters that included tissue color, response to palpation, granulation tissue, incision margin and suppuration.

    Tissue color was further categorized into >50% of red gingiva for grade 1 and 2. For grade 3 tissue color was specified as 25-50% of red gingiva. Less than 25% for grade 4 and all pink tissues for grade 5.Response to palpation was assessed as yes for grade 1 and 2, and no for the remaining three grades. The presence of granulation tissue was examined as yes for grade 1 and 2, and no for grade 3, 4 and 5. If the Incision margin was not epithelialized with loss of epithelium beyond incision margin it was considered grade 1. Incision margin not epithelialized with connective tissue exposure was marked as grade 2. For grade 3, 4 and 5, the connective tissue exposure was nil.

Sponsors and collaborators

Lead sponsor

Rimsha Rasheed

Other

Registry information

Official study title

Effects of Hyaluronic Acid and Corticosteroid in Post Extraction Wound Healing of Diabetic Patients

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 15, 2024
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.